资料单张
LENNON CODEINE PHOSPHATE TABLETS 30 mg
SCHEDULING STATUS:
S6
PROPRIETARY NAME
(and dosage form):
LENNON CODEINE PHOSPHATE TABLETS 30 mg
COMPOSITION:
Tablets containing 30 mg
Codeine Phosphate
.
PHARMACOLOGICAL CLASSIFICATION:
A 2.7 Narcotic Analgesics.
PHARMACOLOGICAL ACTION:
Codeine phosphate is a powerful analgesic which is effective due to its action on the central nervous system. It resembles
morphine in its pharmacodynamic actions although much weaker in its effects. It has little sedative effects.
INDICATIONS:
For the relief of moderate pain.
CONTRA-INDICATIONS:
Codeine Phosphate is contra-indicated in respiratory depression, especially in the presence of cyanosis and excessive
bronchial secretion, as well as acute alcoholism and head injuries, and conditions in which intracranial pressure is raised.
It should not be given during an attack of bronchial asthma or in heart failure secondary to chronic lung disease. The
administration of codeine phosphate is contra-indicated in patients taking monoamine oxidase inhibitors or within
10 days of stopping such treatment.
WARNINGS:
Exceeding prescribed dose, together with prolonged and continuous use of this medication, may lead to dependency and
addiction.
KEEP OUT OF REACH OF CHILDREN
DOSAGE AND DIRECTIONS FOR USE:
15 mg to 60 mg daily.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Codeine phosphate may cause nausea, vomiting, constipation, drowsiness, confusion, dry mouth, sweating, facial
flushing, vertigo, bradycardia, palpitations, orthostatic hypotension, hypothermia, restlessness, changes of mood and
miosis.
Micturition may be difficult, and there may be ureteric or biliary spasm; there is also an antidiuretic effect. Raised
intracranial pressure may occur. Reactions such as urticaria and pruritis may occur. Contact dermatitis has been reported.
阅读完整的文件
资料单张 